FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Anna-Mari Heikkinen

Research Profile

Procedures

Chemicals & Drugs

Concepts & Ideas

Physiology

Disorders

Geographic Areas

Finland

Anatomy

Femur Neck

Co-author Network

Publications

TOP 3
Miia Tiihonen; Riitta Ahonen; Minna Saarela; Suvi Saarinen; Anna-Mari Heikkinen
Menopausal hormone therapy--benefits, adverse reactions, concerns and information sources in 2009.
Miia Tiihonen; Anna-Mari Heikkinen; Hanna-Mari Leppänen; Riitta Ahonen
Information sources used by women in Finland who use hormonal contraceptives.
Timo K Nykopp; Kirsi Rilla; Reijo Sironen; Markku I Tammi; Raija Tammi; Kirsi Hämäläinen; Anna-Mari Heikkinen; Marja Komulainen; Veli-Matti Kosma; Maarit Anttila
Expression of hyaluronan synthases (HAS1-3) and hyaluronidases (HYAL1-2) in serous ovarian carcinomas: inverse correlation between HYAL1 and hyaluronan content.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Anna-Mari Heikkinen (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2011: Miia Tiihonen; Riitta Ahonen; Minna Saarela; Suvi Saarinen; Anna-Mari Heikkinen
Menopausal hormone therapy--benefits, adverse reactions, concerns and information sources in 2009.
Maturitas 2011;70(1):69-73.
2010: Miia Tiihonen; Anna-Mari Heikkinen; Hanna-Mari Leppänen; Riitta Ahonen
Information sources used by women in Finland who use hormonal contraceptives.
Pharmacy world & science : PWS 2010;32(1):66-72.
2009: Timo K Nykopp; Kirsi Rilla; Reijo Sironen; Markku I Tammi; Raija Tammi; Kirsi Hämäläinen; Anna-Mari Heikkinen; Marja Komulainen; Veli-Matti Kosma; Maarit Anttila
Expression of hyaluronan synthases (HAS1-3) and hyaluronidases (HYAL1-2) in serous ovarian carcinomas: inverse correlation between HYAL1 and hyaluronan content.
BMC cancer 2009;9():143.
2008: Marja Komulainen; Heikki Kröger; Marjo Tuppurainen; Anna-Mari Heikkinen; Esko Alhava; Risto Honkanen; Seppo Saarikoski
HRT and Vit D in prevention of non-vertebral fractures in postmenopausal women; a 5 year randomized trial.
Maturitas 2008;61(1-2):85-94.
2008: Miia Tiihonen; Anna-Mari Heikkinen; Hanna-Mari Leppänen; Riitta Ahonen
Hormonal contraceptive users' self-reported benefits, adverse reactions, and fears in 2001 and 2007.
The patient 2008;1(3):173-80.
2007: Miia J Tiihonen; Anna-Mari Heikkinen; Riitta Ahonen
Do Finnish women using hormone replacement therapy need more information about risks.
Pharmacy world & science : PWS 2007;29(6):635-40.
2004: Anna-Mari Heikkinen; Leo Niskanen; Jukka A Salmi; Markku Koulu; Ullamari Pesonen; M I J Uusitupa; Marja Komulainen; Marjo Tuppurainen; Heikki Kröger; Jukka S Jurvelin; Seppo Saarikoski
Leucine7 to proline7 polymorphism in prepro-NPY gene and femoral neck bone mineral density in postmenopausal women.
Bone 2004;35(3):589-94.
2003: Timo Salmén; Anna-Mari Heikkinen; Anitta Mahonen; Heikki Kröger; Marja Komulainen; Heli Pallonen; Seppo Saarikoski; Risto Honkanen; Pekka H Mäenpää
Relation of androgen receptor gene polymorphism to bone mineral density and fracture risk in early postmenopausal women during a 5-year randomized hormone replacement therapy trial.
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 2003;18(2):319-24.
2003: Timo Salmen; Anna-Mari Heikkinen; Anitta Mahonen; Heikki Kröger; Marja Komulainen; Heli Pallonen; Seppo Saarikoski; Risto Honkanen; Pekka H Mäenpää
Relation of aromatase gene polymorphism and hormone replacement therapy to serum estradiol levels, bone mineral density, and fracture risk in early postmenopausal women.
Annals of medicine 2003;35(4):282-8.
2002: Timo Salmén; Anna-Mari Heikkinen; Anitta Mahonen; Heikki Kröger; Marja Komulainen; Seppo Saarikoski; Risto Honkanen; Juhani Partanen; Pekka H Mäenpää
Relation of estrogen receptor-alpha gene polymorphism and hormone replacement therapy to fall risk and muscle strength in early postmenopausal women.
Annals of medicine 2002;34(1):64-72.
2000: Timo Salmén; Anna-Mari Heikkinen; Anitta Mahonen; Heikki Kröger; Marja Komulainen; Seppo Saarikoski; Risto Honkanen; Pekka H Mäenpää
The protective effect of hormone-replacement therapy on fracture risk is modulated by estrogen receptor alpha genotype in early postmenopausal women.
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 2000;15(12):2479-86.
2000: Timo Salmén; Anna-Mari Heikkinen; Anitta Mahonen; Heikki Kröger; Marja Komulainen; Seppo Saarikoski; Risto Honkanen; Pekka H Mäenpää
Early postmenopausal bone loss is associated with PvuII estrogen receptor gene polymorphism in Finnish women: effect of hormone replacement therapy.
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 2000;15(2):315-21.
2000: Anna-Mari Heikkinen; Heikki Kröger; Leo Niskanen; Marja Komulainen; Markku Ryynänen; Markku Parviainen; Marjo Tuppurainen; Risto Honkanen; Seppo Saarikoski
Does apolipoprotein E genotype relate to BMD and bone markers in postmenopausal women?
Maturitas 2000;34(1):33-41.
2000: Marja Komulainen; Heikki Kröger; Marjo Tuppurainen; Anna-Mari Heikkinen; Risto Honkanen; Seppo Saarikoski
Identification of early postmenopausal women with no bone response to HRT: results of a five-year clinical trial.
Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 2000;11(3):211-8.
1999: Marja Komulainen; Heikki Kröger; Marjo Tuppurainen; Anna-Mari Heikkinen; Esko Alhava; Risto Honkanen; Jukka S Jurvelin; Seppo Saarikoski
Prevention of femoral and lumbar bone loss with hormone replacement therapy and vitamin D3 in early postmenopausal women: a population-based 5-year randomized trial.
The Journal of clinical endocrinology and metabolism 1999;84(2):546-52.
1999: Anna-Mari Heikkinen; Leo Niskanen; Markku Ryynänen; Marja Komulainen; Marjo Tuppurainen; Markku Parviainen; Seppo Saarikoski
Is the response of serum lipids and lipoproteins to postmenopausal hormone replacement therapy modified by ApoE genotype?
Arteriosclerosis, thrombosis, and vascular biology 1999;19(2):402-7.
1998: Marja Komulainen; Heikki Kröger; Marjo Tuppurainen; Anna-Mari Heikkinen; Esko Alhava; Risto Honkanen; Seppo Saarikoski
HRT and Vit D in prevention of non-vertebral fractures in postmenopausal women; a 5 year randomized trial.
Maturitas 1998;31(1):45-54.
1998: Anna-Mari Heikkinen; Leo Niskanen; S Ylä-Herttuala; J Luoma; Marjo Tuppurainen; Marja Komulainen; Seppo Saarikoski
Postmenopausal hormone replacement therapy and autoantibodies against oxidized LDL.
Maturitas 1998;29(2):155-61.
1998: Marjo Tuppurainen; Marja Komulainen; Heikki Kröger; Risto Honkanen; Jukka S Jurvelin; E Puntila; Anna-Mari Heikkinen; Esko Alhava; Seppo Saarikoski
Does vitamin D strengthen the increase in femoral neck BMD in osteoporotic women treated with estrogen?
Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 1998;8(1):32-8.
1998: Anna-Mari Heikkinen; Markku Parviainen; Marjo Tuppurainen; Leo Niskanen; Marja Komulainen; Seppo Saarikoski
Effects of postmenopausal hormone replacement therapy with and without vitamin D3 on circulating levels of 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D.
Calcified tissue international 1998;62(1):26-30.
1997: Anna-Mari Heikkinen; Marjo Tuppurainen; Leo Niskanen; Marja Komulainen; I Penttilä; Seppo Saarikoski
Long-term vitamin D3 supplementation may have adverse effects on serum lipids during postmenopausal hormone replacement therapy.
European journal of endocrinology / European Federation of Endocrine Societies 1997;137(5):495-502.
1997: Anna-Mari Heikkinen; Markku Parviainen; Leo Niskanen; Marja Komulainen; Marjo Tuppurainen; Heikki Kröger; Seppo Saarikoski
Biochemical bone markers and bone mineral density during postmenopausal hormone replacement therapy with and without vitamin D3: a prospective, controlled, randomized study.
The Journal of clinical endocrinology and metabolism 1997;82(8):2476-82.
1997: Marja Komulainen; Marjo Tuppurainen; Heikki Kröger; Anna-Mari Heikkinen; E Puntila; Esko Alhava; Risto Honkanen; Seppo Saarikoski
Vitamin D and HRT: no benefit additional to that of HRT alone in prevention of bone loss in early postmenopausal women. A 2.5-year randomized placebo-controlled study.
Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 1997;7(2):126-32.
1995: Marjo Tuppurainen; Anna-Mari Heikkinen; I Penttilä; S Saarikoski
Does vitamin D3 have negative effects on serum levels of lipids? A follow-up study with a sequential combination of estradiol valerate and cyproterone acetate and/or vitamin D3.
Maturitas 1995;22(1):55-61.